Insilico Medicine's AI-driven candidate, Rentosertib, received IND clearance for a direct-to-lung clinical study.
The Story
It is the world's first AI-driven candidate to enter a direct-to-lung clinical study.
Why It Matters
An AI-driven drug candidate, Rentosertib, is now in human trials. This is a real milestone, not a vendor pitch. For European CROs and small biotech, this changes the timeline for competitive drug discovery. Your current pipeline could face faster, AI-accelerated competition. This makes the EU AI Act enforcement in 2026 even more critical.
What To Do About It
Check your internal data governance for GDPR compliance on research data. Before buying new tools, evaluate how Microsoft 365 Copilot could support early-stage research or literature review. I offer workshops on secure, local-first AI adoption for regulated industries.
Sources
Related Signals
Flagright, a new AI operating system for compliance, just secured $12.5M in funding.
17 Jun 2026
Pharma compliance is actively adapting to new AI tools and emerging regulation.
6 Jun 2026
Weverse Brain was selected for South Korea's Ministry of Science and ICT's "Advanced GPU Utilization Support Project".
2 Jun 2026